Dysfunctional immune-privilege in morbid obesity: Implications and effect of gastric bypass surgery

被引:29
|
作者
Cottam, DR [1 ]
Schaefer, PA [1 ]
Shaftan, GW [1 ]
Angus, LDG [1 ]
机构
[1] Nassau Univ, Med Ctr, Dept Surg, E Meadow, NY USA
关键词
morbid obesity; cancer; apoptosis; chronic; inflammation; L-selectin; Fas antigen; CD62L; CD95; lymphocyte; neutrophil; flow cytometry; immune privilege; bariatric surgery; gastric bypass;
D O I
10.1381/096089203321136584
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link. We believe the chronic inflammation present,in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Methods: Leukocytes from 25 patients having gastric,;bypass surgery were compared to 15 normal controls preoperatively and at 1, 3,6, and 12 months post-operatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD 69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. Results: The percentage of CD95+T cells was significantly elevated from controls (69.4% vs 56%, P=0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P=0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P=0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naive T cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P=0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. Conclusion: The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 50 条
  • [1] Dysfunctional Immune-Privilege In Morbid Obesity: Implications and Effect of Gastric Bypass Surgery
    D R Cottam
    P A Schaefer
    G W Shaftan
    L D G Angus
    [J]. Obesity Surgery, 2003, 13 : 49 - 57
  • [2] Gastric bypass surgery in adolscents with morbid obesity
    Strauss, RS
    Bradley, LJ
    Brolin, RE
    [J]. JOURNAL OF PEDIATRICS, 2001, 138 (04): : 499 - 504
  • [3] Therapeutic Implications of Immune-Privilege Mechanisms: Emphasis on ACAID
    Ashour, Hossam M.
    [J]. INTERNET JOURNAL OF MEDICAL UPDATE, 2009, 4 (01) : 1 - 2
  • [4] GASTRIC BYPASS-SURGERY FOR MORBID-OBESITY
    CATLIN, R
    [J]. OBESITY & BARIATRIC MEDICINE, 1980, 9 (03): : 79 - 80
  • [5] Neurologic complications of gastric bypass surgery for morbid obesity
    Juhasz-Pocsine, Katalin
    Rudnicki, Stacy A.
    Archer, Robert L.
    Harik, Sami I.
    [J]. NEUROLOGY, 2007, 68 (21) : 1843 - 1850
  • [6] Gastric bypass surgery in adolescents with morbid obesity.
    Strauss, RS
    Bradley, LJ
    Brolin, RE
    [J]. OBESITY RESEARCH, 2000, 8 : 46S - 46S
  • [7] SURGERY FOR MORBID OBESITY - COMPARISON OF JEJUNOILEAL AND GASTRIC BYPASS
    RUBENSTEIN, RB
    FISCHER, MG
    [J]. NEW YORK STATE JOURNAL OF MEDICINE, 1979, 79 (08) : 1227 - 1229
  • [8] Morbid Obesity and Gastric Bypass Surgery: Biochemical Profile
    V Silvestre
    M Ruano
    Y Domínguez
    R Castro
    MC G García-Lescun
    A Rodríguez
    A Marco
    G García-Blanch
    [J]. Obesity Surgery, 2004, 14 : 1227 - 1232
  • [9] Morbid obesity and gastric bypass surgery:: Biochemical profile
    Silvestre, V
    Ruano, M
    Domínguez, Y
    Castro, R
    García-Lescun, MCG
    Rodríguez, A
    Marco, A
    García-Blanch, G
    [J]. OBESITY SURGERY, 2004, 14 (09) : 1227 - 1232
  • [10] Pregnancy following gastric bypass surgery for morbid obesity
    Gurewitsch, ED
    SmithLevitin, M
    Mack, J
    [J]. OBSTETRICS AND GYNECOLOGY, 1996, 88 (04): : 658 - 661